62124-30-5

Basic information

• Product Name: 1-(2-HYDROXY-ETHYL)-PIPERIDINE-4-CARBOXYLIC ACID AMIDE
• Synonyms: 1-(2-hydroxyethyl)piperidine-4-carboxamide
• CAS NO: 62124-30-5
• Molecular Formula: C8H16N2O2
• Molecular Weight: 172.22
• Mol File: 62124-30-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 384.7°C at 760 mmHg
• Flash Point: 186.5°C
• Appearance: /
• Density: 1.14g/cm³
• Vapor Pressure: 1.67E-07mmHg at 25°C
• Refractive Index: 1.515
• PKA: 15.00±0.10(Predicted)
• CAS DataBase Reference: 1-(2-HYDROXY-ETHYL)-PIPERIDINE-4-CARBOXYLIC ACID AMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-HYDROXY-ETHYL)-PIPERIDINE-4-CARBOXYLIC ACID AMIDE(62124-30-5)
• EPA Substance Registry System: 1-(2-HYDROXY-ETHYL)-PIPERIDINE-4-CARBOXYLIC ACID AMIDE(62124-30-5)

Safety Data

• Hazardous Substances Data: 62124-30-5(Hazardous Substances Data)

Usage

General Description

1-(2-Hydroxy-ethyl)-piperidine-4-carboxylic acid amide is a chemical compound with a molecular structure consisting of a piperidine ring attached to a carboxylic acid amide group and a hydroxyl-ethyl side chain. 1-(2-HYDROXY-ETHYL)-PIPERIDINE-4-CARBOXYLIC ACID AMIDE has potential applications in the pharmaceutical industry, particularly for its potential use as a building block in the synthesis of bioactive compounds. Its presence of a piperidine ring suggests potential biological activity, as piperidine derivatives are known to exhibit a wide range of pharmacological effects. Further research and analysis are needed to determine the exact properties and potential uses of this compound in pharmaceutical and other industries.

InChI:InChI=1/C8H16N2O2/c9-8(12)7-1-3-10(4-2-7)5-6-11/h7,11H,1-6H2,(H2,9,12)

Upstream product

• 75-21-8 oxirane 
• 39546-32-2 4-carboxamidopiperidine 
• 540-51-2 2-bromoethanol 
• 107-07-3 2-chloro-ethanol 

Downstream Products

• 21168-72-9 2-(4-(aminomethyl)piperidin-1-yl)ethan-1-ol 
• 26458-78-6 4-cyanoquinuclidine 
• 111041-03-3 1-(2-chloroethyl)piperidine-4-carbonitrile hydrochloride 

Relevant articles and documents

Modulators of STING (Stimulator of Interferon Genes)

Compounds of the general formula (I): or a pharmaceutically acceptable salt thereof, processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.

Anti-Hiv Quinuclidine Compounds

The invention provides a therapeutic method for preventing or treating a pathological condition or symptom in a mammal, such as a human, wherein the infectivity of a pathogen such as a retrovirus toward mammalian cells is implicated and inhibition of its

LTA4 Hydrolase inhibitors

The present invention provides compounds of the formula Ar1-Q-Ar2-Y-R-Z and pharmaceutically acceptable salts thereof wherein Ar1 and Ar2 are optionally substituted aryl moieties, Z is an optionally substituted nitrogen-containing moiety which may be an acyclic, cyclic or bicyclic amine or an optionally substituted monocyclic or bicyclic nitrogen-containing heteroaromatic moiety; Q is a linking group capable of linking two aryl groups; R is an alkylene moiety; Y is a linking moiety capable of linking an aryl group to an alkylene moiety and wherein Z is bonded to R through a nitrogen atom. The compounds and pharmaceutical compositions of the present invention are useful in the treatment of inflammatory diseases which are mediated by LTB4 production, such as proriasis, ulcerative colitis, IBD and asthma.